Table 1 Demographic, clinical, and laboratory characteristics of participants
From: Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
| Â | HCC (n = 25) | Cirrhosis (n = 25) | Controls (n = 25) |
|---|---|---|---|
Age | 57.20 ± 6.26 | 61.80 ± 9.34 | 61.0 ± 7.07 |
Males | 15 (60%) | 19 (76%) | 11 (44%) |
BMI | 26.68 ± 3.44 | 28.04 ± 2.68 | 28.28 ± 4.26 |
Child-Pugh | |||
 A | 3 (12%) | 6 (24%) |  |
 B | 12 (48%) | 13 (52%) |  |
 C | 10 (40%) | 6 (24%) |  |
BCLC | |||
 A | 2 (8%) |  |  |
 B | 10 (40%) |  |  |
 C | 8 (32%) |  |  |
 D | 5 (20%) |  |  |
Hb | 12.82 ± 14.02 | 10.38 ± 2.24 |  |
Platelets | 79.0 (55.0-101.0) | 104.0 (62.0-136.0) | Â |
WBC | 4.56 (2.83-5.20) | 5.70 (3.51-8.43) | Â |
AST | 75.0 (42.0-91.0) | 44.0 (30.0-59.0) | Â |
Albumin | 2.50 ± 0.89 | 2.51 ± 0.52 |  |
Bilirubin | 2.40 (1.30-4.30) | 1.70 (1.0-3.10) | Â |
INR | 1.46 ± 0.44 | 1.41 ± 0.22 |  |
ALT | 37.0 (33.0-42.0) | 26.0 (19.0-42.0) | Â |
AFP | 777.5 ± 451.1 |  |  |